Morgan Stanley Longboard Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 78,645 shares of LBPH stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,645

Previous 83,560 5.88%

Holding current value

$4.69 Million

Previous $1.8 Million 17.79%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$17.0 - $27.03 $83,555 - $132,852	-4,915 Reduced 5.88%	78,645 $2.13 Million
Q2 2024 Aug 14, 2024	SELL	$17.0 - $27.03 $83,555 - $132,852	-4,915 Reduced 5.88%	78,645 $2.13 Million
Q1 2024 Oct 17, 2024	BUY	$18.89 - $26.06 $92,844 - $128,084	4,915 Added 6.25%	83,560 $1.8 Million
Q1 2024 Aug 16, 2024	BUY	$18.89 - $26.06 $977,293 - $1.35 Million	51,736 Added 162.57%	83,560 $1.8 Million
Q1 2024 May 15, 2024	BUY	$18.89 - $26.06 $977,293 - $1.35 Million	51,736 Added 162.57%	83,560 $1.8 Million
Q4 2023 Aug 16, 2024	SELL	$3.68 - $6.5 $172,301 - $304,336	-46,821 Reduced 59.53%	31,824 $191,000
Q4 2023 Feb 13, 2024	BUY	$3.68 - $6.5 $91,124 - $160,953	24,762 Added 350.64%	31,824 $191,000
Q3 2023 Nov 15, 2023	SELL	$5.49 - $7.49 $20,631 - $28,147	-3,758 Reduced 34.73%	7,062 $39,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $10.05 $44,627 - $107,042	10,651 Added 6302.37%	10,820 $79,000
Q1 2023 May 15, 2023	BUY	$3.84 - $5.96 $637 - $989	166 Added 5533.33%	169 $0
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.7 $8 - $14	3 New	3 $0
Q2 2022 Aug 15, 2022	SELL	$2.96 - $5.38 $14 - $26	-5 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$4.0 - $6.0 $20 - $30	5 New	5 $0
Q1 2022 May 13, 2022	BUY	$4.0 - $6.0 $16 - $24	4 Added 400.0%	5 $0
Q4 2021 Feb 14, 2022	BUY	$4.75 - $9.45 $4 - $9	1 New	1 $0

Others Institutions Holding LBPH

# of Institutions

104

Shares Held

34.2M

Call Options Held

8.5K

Put Options Held

31.1K

View Full List

About Longboard Pharmaceuticals, Inc.

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $811M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

More about LBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account